Drugs / IFN-α
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04565262 | Sep 2020 → Jul 2023 | chronic hepatitis B virus infection | Beijing 302 Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-α | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04565262 ↗ |